Akanchise Thelma, Angelova Angelina
Université Paris-Saclay, CNRS, Institut Galien Paris-Saclay, 91400 Orsay, France.
Pharmaceutics. 2023 May 22;15(5):1562. doi: 10.3390/pharmaceutics15051562.
Coronavirus infections are neuroinvasive and can provoke injury to the central nervous system (CNS) and long-term illness consequences. They may be associated with inflammatory processes due to cellular oxidative stress and an imbalanced antioxidant system. The ability of phytochemicals with antioxidant and anti-inflammatory activities, such as Ginkgo biloba, to alleviate neurological complications and brain tissue damage has attracted strong ongoing interest in the neurotherapeutic management of long COVID. Ginkgo biloba leaf extract (EGb) contains several bioactive ingredients, e.g., bilobalide, quercetin, ginkgolides A-C, kaempferol, isorhamnetin, and luteolin. They have various pharmacological and medicinal effects, including memory and cognitive improvement. Ginkgo biloba, through its anti-apoptotic, antioxidant, and anti-inflammatory activities, impacts cognitive function and other illness conditions like those in long COVID. While preclinical research on the antioxidant therapies for neuroprotection has shown promising results, clinical translation remains slow due to several challenges (e.g., low drug bioavailability, limited half-life, instability, restricted delivery to target tissues, and poor antioxidant capacity). This review emphasizes the advantages of nanotherapies using nanoparticle drug delivery approaches to overcome these challenges. Various experimental techniques shed light on the molecular mechanisms underlying the oxidative stress response in the nervous system and help comprehend the pathophysiology of the neurological sequelae of SARS-CoV-2 infection. To develop novel therapeutic agents and drug delivery systems, several methods for mimicking oxidative stress conditions have been used (e.g., lipid peroxidation products, mitochondrial respiratory chain inhibitors, and models of ischemic brain damage). We hypothesize the beneficial effects of EGb in the neurotherapeutic management of long-term COVID-19 symptoms, evaluated using either in vitro cellular or in vivo animal models of oxidative stress.
冠状病毒感染具有神经侵袭性,可引发中枢神经系统(CNS)损伤及长期疾病后果。它们可能与细胞氧化应激和抗氧化系统失衡导致的炎症过程有关。具有抗氧化和抗炎活性的植物化学物质,如银杏,减轻神经并发症和脑组织损伤的能力,在长期新冠的神经治疗管理中引起了持续的浓厚兴趣。银杏叶提取物(EGb)含有多种生物活性成分,如白果内酯、槲皮素、银杏内酯A - C、山奈酚、异鼠李素和木犀草素。它们具有多种药理和药用作用,包括改善记忆和认知。银杏通过其抗凋亡、抗氧化和抗炎活性,影响认知功能以及长期新冠等其他疾病状况。虽然神经保护抗氧化疗法的临床前研究已显示出有前景的结果,但由于若干挑战(如药物生物利用度低、半衰期有限、稳定性差、靶向组织递送受限以及抗氧化能力不足),临床转化仍然缓慢。本综述强调了使用纳米颗粒药物递送方法的纳米疗法在克服这些挑战方面的优势。各种实验技术揭示了神经系统氧化应激反应的分子机制,并有助于理解SARS-CoV-2感染神经后遗症的病理生理学。为开发新型治疗剂和药物递送系统,已使用了几种模拟氧化应激条件的方法(如脂质过氧化产物、线粒体呼吸链抑制剂和缺血性脑损伤模型)。我们假设EGb在长期新冠症状的神经治疗管理中具有有益作用,这可通过氧化应激的体外细胞模型或体内动物模型进行评估。
Drugs R D. 2003
Pharmacopsychiatry. 2003-6
Antioxidants (Basel). 2023-2-6
Arch Pharm (Weinheim). 2022-10
Planta Med. 2020-2-25
Int J Biomater. 2025-7-9
Nanotechnol Sci Appl. 2024-9-23
Int J Mol Sci. 2024-4-7
Brain Commun. 2024-3-7
Antioxidants (Basel). 2023-2-6
Diabetes Metab Syndr. 2022-12
J Clin Invest. 2022-8-1
Antioxidants (Basel). 2022-6-3
Arch Pharm (Weinheim). 2022-10